In this study, we investigated the effects of the Lyp variant on the immune and autoimmune responses, particularly regarding the peripheral blood B cell function, in T1D patients and healthy controls following CpG-induced stimulation. Here, PTPN22 is linked to type 1 diabetes mellitus.